[1]
Yu, X., Liu, J., Qiu, H., Hao, H., Zhu, J. and Peng, S. 2021. Combined inhibition of ACK1 and AKT shows potential toward targeted therapy against KRAS-mutant non-small-cell lung cancer. Bosnian Journal of Basic Medical Sciences. 21, 2 (Apr. 2021), 198-207. DOI:https://doi.org/10.17305/bjbms.2020.4746.